Novavax, Inc. (NVAX) Reports In-Line Q1 EPS

Novavax, Inc. (NASDAQ: NVAX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $7.5 million, versus $3.8 million reported last year.

For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c